Almitas Capital LLC reported 52 positions worth $182.67M for the quarter ended Jun 30, 2026, down 19.9% on the prior quarter. It opened 13 new positions, added to 6, trimmed 11 and exited 7. Its largest holding is Fidelity Wise Origin Bitcoin Fund at 38.1% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| FBRT Franklin BSP Realty Trust, Inc. | +199.1K | +201.0% | $1.62M | 1.33% |
| LUNG Pulmonx Corp | +1.06M | – | $1.38M | 0.757% |
| AEM Agnico Eagle Mines Ltd | +8,035 | – | $1.25M | 0.682% |
| NEM NEWMONT Corp | +6,800 | – | $635.12K | 0.348% |
| ACRE Ares Commercial Real Estate Corp | +130.0K | +254.8% | $584.81K | 0.446% |
| LADR Ladder Capital Corp | +50.0K | +17.2% | $497.50K | 1.85% |
| TORO Toro Corp. | +100.0K | – | $487.00K | 0.267% |
| BNY Bank of New York Mellon Corp | +3,300 | – | $477.21K | 0.261% |
| MTB M&T Bank Corp | +1,800 | – | $428.42K | 0.235% |
| PNC Pnc Financial Services Group, Inc. | +1,700 | – | $418.57K | 0.229% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. | -1.15M | -54.1% | $20.61M | 9.58% |
| FBTC Fidelity Wise Origin Bitcoin Fund | -172.1K | -11.2% | $8.79M | 38.13% |
| BIO Bio-Rad Laboratories, Inc. | -30.3K | -100.0% | $8.43M | Exited |
| DSGN Design Therapeutics, Inc. | -503.4K | -32.9% | $7.28M | 8.13% |
| MSGS Madison Square Garden Sports Corp. | -9,925 | -100.0% | $3.19M | Exited |
| MYPS PLAYSTUDIOS, Inc. | -412.5K | -87.7% | $2.06M | 0.158% |
| ANRO Alto Neuroscience, Inc. | -78.5K | -100.0% | $1.77M | Exited |
| ZNTL Zentalis Pharmaceuticals, Inc. | -610.1K | -100.0% | $1.43M | Exited |
| BRSP BrightSpire Capital, Inc. | -246.9K | -24.3% | $1.35M | 2.29% |
| RLYB Rallybio Corp | -70.5K | -36.9% | $1.13M | 1.06% |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| LUNG Pulmonx Corp | +1.06M | $1.38M | 0.757% |
| AEM Agnico Eagle Mines Ltd | +8,035 | $1.25M | 0.682% |
| NEM NEWMONT Corp | +6,800 | $635.12K | 0.348% |
| TORO Toro Corp. | +100.0K | $487.00K | 0.267% |
| BNY Bank of New York Mellon Corp | +3,300 | $477.21K | 0.261% |
| MTB M&T Bank Corp | +1,800 | $428.42K | 0.235% |
| PNC Pnc Financial Services Group, Inc. | +1,700 | $418.57K | 0.229% |
| NTRS Northern Trust Corp | +2,400 | $417.22K | 0.228% |
| TFC Truist Financial Corp | +7,800 | $388.60K | 0.213% |
| FNV FRANCO NEVADA Corp | +1,690 | $352.26K | 0.193% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| BIO Bio-Rad Laboratories, Inc. | -30.3K | $8.43M | 3.7% |
| MSGS Madison Square Garden Sports Corp. | -9,925 | $3.19M | 1.4% |
| ANRO Alto Neuroscience, Inc. | -78.5K | $1.77M | 0.774% |
| ZNTL Zentalis Pharmaceuticals, Inc. | -610.1K | $1.43M | 0.626% |
| HPP Hudson Pacific Properties, Inc. | -124.4K | $735.19K | 0.322% |
| GAB-R Gabelli Equity Trust Inc. RT EXP 041426 | -270.7K | $1.90K | <0.01% |
| NHS-R Neuberger High Yield Strategies Rights | -110.0K | $880.00 | <0.01% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | FBTC Fidelity Wise Origin Bitcoin Fund | Others | 1.36M | $69.66M | 38.13% | -172.1K | -11.2% | Reduced | 0.68% |
| 2 | AMLX Amylyx Pharmaceuticals, Inc. | Healthcare | 974.9K | $17.51M | 9.58% | -1.15M | -54.1% | Reduced | 0.88% |
| 3 | DSGN Design Therapeutics, Inc. | Healthcare | 1.03M | $14.86M | 8.13% | -503.4K | -32.9% | Reduced | 1.64% |
| 4 | CNNE Cannae Holdings, Inc. | Financial Services | 741.3K | $10.67M | 5.84% | 0 | 0.0% | Unchanged | 1.7% |
| 5 | LYEL Lyell Immunopharma, Inc. | Healthcare | 581.4K | $8.17M | 4.47% | +3,600 | +0.6% | Added | 2.48% |
| 6 | ANTX AN2 Therapeutics, Inc. | Healthcare | 1.47M | $7.11M | 3.89% | -10.0K | -0.7% | Reduced | 3.28% |
| 7 | ALXO Alx Oncology Holdings Inc | Healthcare | 2.94M | $6.08M | 3.33% | -235.4K | -7.4% | Reduced | 2.13% |
| 8 | BRSP BrightSpire Capital, Inc. | Financial Services | 769.0K | $4.19M | 2.29% | -246.9K | -24.3% | Reduced | 0.61% |
| 9 | CCAP Crescent Capital BDC, Inc. | Financial Services | 356.9K | $3.90M | 2.13% | 0 | 0.0% | Unchanged | 0.97% |
| 10 | ELME Elme Communities | Real Estate | 2.62M | $3.88M | 2.12% | +11.9K | +0.5% | Added | 2.95% |
| 11 | LADR Ladder Capital Corp | Financial Services | 340.5K | $3.39M | 1.85% | +50.0K | +17.2% | Added | 0.27% |
| 12 | TRTX TPG RE Finance Trust, Inc. | Financial Services | 362.7K | $3.04M | 1.66% | +34.9K | +10.6% | Added | 0.47% |
| 13 | EBF Ennis, Inc. | Communication Services | 139.0K | $2.95M | 1.62% | 0 | 0.0% | Unchanged | 0.55% |
| 14 | FBRT Franklin BSP Realty Trust, Inc. | Financial Services | 298.2K | $2.43M | 1.33% | +199.1K | +201.0% | Added | 0.39% |
| 15 | FLGT Fulgent Genetics, Inc. | Healthcare | 104.8K | $2.15M | 1.18% | 0 | 0.0% | Unchanged | 0.37% |
Tip. Select a row to see that position’s full history at Almitas Capital.
As of its Q2 2026 13F filing, Almitas Capital LLC’s five largest positions were Fidelity Wise Origin Bitcoin Fund (FBTC) at 38.1%, Amylyx Pharmaceuticals, Inc. (AMLX) at 9.6%, Design Therapeutics, Inc. (DSGN) at 8.1%, Cannae Holdings, Inc. (CNNE) at 5.8%, Lyell Immunopharma, Inc. (LYEL) at 4.5% of the reported portfolio.
Almitas Capital LLC reported a 13F portfolio worth $182.67M across 52 positions for Q2 2026. That is down 19.9% from the previous quarter.
Its largest purchases by value were Franklin BSP Realty Trust, Inc. ($1.62M), Pulmonx Corp ($1.38M), Agnico Eagle Mines Ltd ($1.25M). It opened 13 new positions.
Its largest sales by value were Amylyx Pharmaceuticals, Inc. ($20.61M), Fidelity Wise Origin Bitcoin Fund ($8.79M), Bio-Rad Laboratories, Inc. ($8.43M). It exited 7 positions entirely.
From the Form 13F-HR reports Almitas Capital LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.